Bd Biosciences

85
Bd Biosciences
Bd Biosciences is listed in the Physicians & Surgeons Equipment & Supplies category in San Jose, California. Displayed below are the social networks for Bd Biosciences which include a Facebook page, a Linkedin company page, a Twitter account and a YouTube channel. The activity and popularity of Bd Biosciences on these social networks gives it a ZapScore of 85.

Contact information for Bd Biosciences is:
2350 Qume Dr
San Jose, CA 95131
(408) 432-9475

"Bd Biosciences" - ZapScore Report

85
Bd Biosciences has an overall ZapScore of 85. This means that Bd Biosciences has a higher ZapScore than 85% of all businesses on Zappenin. For reference, the median ZapScore for a business in San Jose, California is 36 and in the Physicians & Surgeons Equipment & Supplies category is 35. Learn more about ZapScore

Do you own or manage this business? Click here to claim the Bd Biosciences listing and add social networks, logos, descriptions and more.

Bd Biosciences Contact Information:

Social Posts for Bd Biosciences


The integrated #PyxisES has #med workflow benefits which extends beyond #nursing to #pharmacy. Watch the UConn vide twitter.com/i/web/status/8…

BD (Becton, Dickinson and Company) added 2 new photos.
The BD Life Sciences – Diagnostic Systems leadership team recently hosted United States Senator Chris Van Hollen at BD’s Sparks, Maryland campus. Senator Van Hollen met with the Sparks team to learn more about the Diagnostic Systems business and took a tour of our high-tech instrument manufacturing plant. Senator Van Hollen also received an exclusive tour of our new Global Services Learning Lab, a state-of-the-art multi-use space designed to give customers and BD associates hands-on training experience.


Come see at #NTI2017 how a patient-centric approach to #medmanagement can help improve safety and efficiency, BD bo twitter.com/i/web/status/8…


BD at the pleasure of hosting US Senator Chris Van Hollen on a tour of the BD campus in Sparks, MD. https://t.co/sUk8qzlBXs


RT @njassemblydems: .@angiemj319 Green @RajMukherji & @aswsumter Bill to Establish Rules for Handling of Hazardous Drugs Now Law https://t.…

At BD, we’re committed to providing health care workers with the proper protections required to handle hazardous drugs that can help save the lives of patients in need. It is because of this commitment that we would like to commend Assemblywoman Angelica Jimenez (D-Hudson) for advancing health care worker safety in New Jersey by championing (A-837) “Hazardous Drug Safe Handling Act” into law. http://bddy.me/2qx91nd


Hospitals spend $70B+ annually on managing diversion. Register for Manage Controlled Substances webinar on 5/24 twitter.com/i/web/status/8…

Learn more about how BD and Bard will deliver innovative healthcare solutions http://bdandbard.transactionannouncement.com/

Check out company leaders discussing BD’s proposed acquisition of Bard, which will create a highly differentiated medical technology company uniquely focused on delivering innovative healthcare solutions to improve clinical and economic outcomes. https://www.youtube.com/watch?v=8APAEfBojL0
Check out company leaders discussing BD's proposed acquisition of Bard, which will create a highly differentiated medical technology company uniquely focused on delivering innovative healthcare solutions to improve clinical and economic outcomes.

Exciting news: BD is thrilled to announce the proposed acquisition of C.R. Bard, Inc. We believe the combination will create a highly differentiated medical technology company uniquely focused on delivering innovative healthcare solutions to improve clinical and economic outcomes. We look forward to welcoming Bard’s talented employees to our strong and dedicated team. For more information, please click here: http://bddy.me/2q4qAJS
BD and Bard announced on April 23, 2017 that they have entered into a definitive agreement under which BD will acquire Bard for $317.00 per Bard common share in cash and stock, for a total consideration of $24 billion, creating a highly differentiated medical technology company focused on delivering...